Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) announced today that it will acquire 23andMe for a purchase price of $256 million.

For decades, humans have prided themselves on being the only species capable of complex medical care stitching wounds, ...

Who wants to live forever? Lots of us do, it seems. Australians are searching for terms like “longevity” more than ever and social media is full of longevity advice. Living longer is high on the ...

The award-winning chief creative officer discusses leaving ANZ at its peak, joining Accenture Song UK, and what's next for ...

Before you get in the water this summer, take a peek at the many ocean mysteries lurking below Dive deep into ocean mysteries ...

Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe for $256 million through a bankruptcy auction, the ...

Bankrupt genetic-testing firm 23andMe agreed to sell its data bank, which once contained DNA samples from about 15 million ...

After the slow-burn brilliance of 'The Climb,' he returns to Cannes with an uproarious open-relationship comedy starring ...

Many attempts have been made to help men and women find common ground, with John Gray's book Men Are from Mars, Women Are ...

British officers and crew members set out in search of the Northwest Passage on HMS "Erebus" and HMS "Terror." None returned ...